• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射呋塞米治疗急性失代偿性充血性心力衰竭:有何证据?

Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?

机构信息

Division of Brain Sciences, Imperial College, Hammersmith Hospital, London, UK.

Centre for Clinical Pharmacology, University College London, London, UK.

出版信息

Clin Pharmacol Ther. 2015 Aug;98(2):119-21. doi: 10.1002/cpt.120. Epub 2015 Jun 30.

DOI:10.1002/cpt.120
PMID:25786394
Abstract

Use of intravenous furosemide rather than oral administration in acute decompensated congestive cardiac failure is universally recommended in international guidelines. We argue that this recommendation is not supported by the existing evidence, and suggest that trials should be performed to determine whether larger doses of oral furosemide should be prescribed prior to an IV switch. This could reduce length of hospital admissions and allow for more patients to be managed in the primary care setting.

摘要

在国际指南中,普遍建议在急性失代偿性充血性心力衰竭中使用静脉注射呋塞米而非口服给药。我们认为,这一建议没有现有证据支持,并建议进行试验以确定在进行静脉注射转换之前是否应该开更大剂量的口服呋塞米。这可以缩短住院时间,并使更多患者能够在初级保健环境中得到管理。

相似文献

1
Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?静脉注射呋塞米治疗急性失代偿性充血性心力衰竭:有何证据?
Clin Pharmacol Ther. 2015 Aug;98(2):119-21. doi: 10.1002/cpt.120. Epub 2015 Jun 30.
2
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
3
Furosemide in acute decompensated heart failure.速尿在急性失代偿性心力衰竭中的应用
Prescrire Int. 2012 Dec;21(133):303.
4
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.大剂量呋塞米与小剂量多巴胺治疗难治性充血性心力衰竭时的毒性增加。
Clin Pharmacol Ther. 1997 Aug;62(2):187-93. doi: 10.1016/S0009-9236(97)90067-9.
5
Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.在接受静脉注射呋塞米治疗心力衰竭的患者中,口服氢氯噻嗪或静脉注射氯噻嗪联合利尿疗法效果的比较。
Pharmacotherapy. 2014 Aug;34(8):882-7. doi: 10.1002/phar.1456. Epub 2014 Jul 3.
6
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.入院时的肾功能改变利尿剂在急性心力衰竭中的预后影响:倾向评分匹配及交互分析
Heart Vessels. 2016 Dec;31(12):1980-1987. doi: 10.1007/s00380-016-0817-y. Epub 2016 Feb 18.
7
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.大剂量呋塞米与小容量高渗盐溶液输注对比大剂量呋塞米推注治疗难治性充血性心力衰竭的长期效果
Am Heart J. 2003 Mar;145(3):459-66. doi: 10.1067/mhj.2003.166.
8
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.托拉塞米和呋塞米在充血性心力衰竭患者中的生物利用度、药代动力学及药效学
Clin Pharmacol Ther. 1995 Jun;57(6):601-9. doi: 10.1016/0009-9236(95)90222-8.
9
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).静脉注射大剂量呋塞米联合高渗盐水治疗失代偿性心力衰竭试验(Tra-HSS-Fur)后的肌钙蛋白 I 释放。
Am Heart J. 2012 Sep;164(3):351-7. doi: 10.1016/j.ahj.2012.05.025. Epub 2012 Aug 17.
10
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.A1-腺苷受体拮抗剂BG9719(CVT-124)和呋塞米对充血性心力衰竭患者肾小球滤过率及利钠作用的影响。
J Am Coll Cardiol. 2000 Jan;35(1):56-9. doi: 10.1016/s0735-1097(99)00532-x.

引用本文的文献

1
Subcutaneous Furosemide Therapy for Chronic Management of Refractory Congestive Heart Failure in Dogs and Cats.皮下注射速尿疗法用于犬猫难治性充血性心力衰竭的长期管理
Animals (Basel). 2025 Jan 26;15(3):358. doi: 10.3390/ani15030358.
2
Effect of diuretic infusion clinic in preventing hospitalization for patients with decompensating heart failure.利尿剂输注门诊对失代偿性心力衰竭患者预防住院的作用。
SAGE Open Med. 2020 Jul 4;8:2050312120940094. doi: 10.1177/2050312120940094. eCollection 2020.
3
Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.
皮下注射速尿治疗心力衰竭:一种新的缓冲溶液的药代动力学特征
JACC Basic Transl Sci. 2018 Feb 7;3(1):25-34. doi: 10.1016/j.jacbts.2017.10.001. eCollection 2018 Feb.